148 related articles for article (PubMed ID: 28444532)
1. The Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaLuAtion (UMBRELLA): objectives, design, and baseline results.
Young-Afat DA; van Gils CH; van den Bongard HJGD; Verkooijen HM;
Breast Cancer Res Treat; 2017 Jul; 164(2):445-450. PubMed ID: 28444532
[TBL] [Abstract][Full Text] [Related]
2. The effects of exercise on the quality of life of patients with breast cancer (the UMBRELLA Fit study): study protocol for a randomized controlled trial.
Gal R; Monninkhof EM; Groenwold RHH; van Gils CH; van den Bongard DHJG; Peeters PHM; Verkooijen HM; May AM
Trials; 2017 Oct; 18(1):504. PubMed ID: 29078800
[TBL] [Abstract][Full Text] [Related]
3. The Trials within Cohorts design faced methodological advantages and disadvantages in the exercise oncology setting.
Gal R; Monninkhof EM; van Gils CH; Groenwold RHH; van den Bongard DHJG; Peeters PHM; Verkooijen HM; May AM
J Clin Epidemiol; 2019 Sep; 113():137-146. PubMed ID: 31146022
[TBL] [Abstract][Full Text] [Related]
4. Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors.
Bargon CA; Batenburg MCT; van Stam LE; Mink van der Molen DR; van Dam IE; van der Leij F; Baas IO; Ernst MF; Maarse W; Vermulst N; Schoenmaeckers EJP; van Dalen T; Bijlsma RM; Young-Afat DA; Doeksen A; Verkooijen HM
JNCI Cancer Spectr; 2021 Feb; 5(1):pkaa104. PubMed ID: 33437925
[TBL] [Abstract][Full Text] [Related]
5. Assessing the effect of hyperbaric oxygen therapy in breast cancer patients with late radiation toxicity (HONEY trial): a trial protocol using a trial within a cohort design.
Batenburg MCT; van den Bongard HJGD; Kleynen CE; Maarse W; Witkamp A; Ernst M; Doeksen A; van Dalen T; Sier M; Schoenmaeckers EJP; Baas IO; Verkooijen HM
Trials; 2020 Nov; 21(1):980. PubMed ID: 33246494
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research.
Burbach JP; Kurk SA; Coebergh van den Braak RR; Dik VK; May AM; Meijer GA; Punt CJ; Vink GR; Los M; Hoogerbrugge N; Huijgens PC; Ijzermans JN; Kuipers EJ; de Noo ME; Pennings JP; van der Velden AM; Verhoef C; Siersema PD; van Oijen MG; Verkooijen HM; Koopman M
Acta Oncol; 2016 Nov; 55(11):1273-1280. PubMed ID: 27560599
[TBL] [Abstract][Full Text] [Related]
8. Telephone interventions for symptom management in adults with cancer.
Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
[TBL] [Abstract][Full Text] [Related]
9. Home-based multidimensional survivorship programmes for breast cancer survivors.
Cheng KKF; Lim YTE; Koh ZM; Tam WWS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
[TBL] [Abstract][Full Text] [Related]
10. RandomizEd controlled trial for pre-operAtive dose-escaLation BOOST in locally advanced rectal cancer (RECTAL BOOST study): study protocol for a randomized controlled trial.
Burbach JP; Verkooijen HM; Intven M; Kleijnen JP; Bosman ME; Raaymakers BW; van Grevenstein WM; Koopman M; Seravalli E; van Asselen B; Reerink O
Trials; 2015 Feb; 16():58. PubMed ID: 25888548
[TBL] [Abstract][Full Text] [Related]
11. Effects of exercise in breast cancer patients: implications of the trials within cohorts (TwiCs) design in the UMBRELLA Fit trial.
Gal R; Monninkhof EM; van Gils CH; Groenwold RHH; Elias SG; van den Bongard DHJG; Peeters PHM; Verkooijen HM; May AM
Breast Cancer Res Treat; 2021 Nov; 190(1):89-101. PubMed ID: 34427806
[TBL] [Abstract][Full Text] [Related]
12. The trials within cohorts design facilitated efficient patient enrollment and generalizability in oncology setting.
Couwenberg AM; Burbach JPM; May AM; Berbee M; Intven MPW; Verkooijen HM
J Clin Epidemiol; 2020 Apr; 120():33-39. PubMed ID: 31866471
[TBL] [Abstract][Full Text] [Related]
13. Oncology patients were found to understand and accept the Trials within Cohorts design.
Young-Afat DA; Gal R; Gerlich S; Burbach JPM; van der Velden JM; van den Bongard DHJG; Intven MPW; Kasperts N; May AM; van der Graaf R; van Gils CH; Verkooijen HM
J Clin Epidemiol; 2021 Feb; 130():135-142. PubMed ID: 33130236
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
15. Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative.
Coebergh van den Braak RRJ; van Rijssen LB; van Kleef JJ; Vink GR; Berbee M; van Berge Henegouwen MI; Bloemendal HJ; Bruno MJ; Burgmans MC; Busch ORC; Coene PPLO; Coupé VMH; Dekker JWT; van Eijck CHJ; Elferink MAG; Erdkamp FLG; van Grevenstein WMU; de Groot JWB; van Grieken NCT; de Hingh IHJT; Hulshof MCCM; Ijzermans JNM; Kwakkenbos L; Lemmens VEPP; Los M; Meijer GA; Molenaar IQ; Nieuwenhuijzen GAP; de Noo ME; van de Poll-Franse LV; Punt CJA; Rietbroek RC; Roeloffzen WWH; Rozema T; Ruurda JP; van Sandick JW; Schiphorst AHW; Schipper H; Siersema PD; Slingerland M; Sommeijer DW; Spaander MCW; Sprangers MAG; Stockmann HBAC; Strijker M; van Tienhoven G; Timmermans LM; Tjin-A-Ton MLR; van der Velden AMT; Verhaar MJ; Verkooijen HM; Vles WJ; de Vos-Geelen JMPGM; Wilmink JW; Zimmerman DDE; van Oijen MGH; Koopman M; Besselink MGH; van Laarhoven HWM;
Acta Oncol; 2018 Feb; 57(2):195-202. PubMed ID: 28723307
[TBL] [Abstract][Full Text] [Related]
16. A complex nursing intervention of complementary and alternative medicine (CAM) to increase quality of life in patients with breast and gynecologic cancer undergoing chemotherapy: study protocol for a partially randomized patient preference trial.
Klafke N; Mahler C; von Hagens C; Rochon J; Schneeweiss A; Müller A; Salize HJ; Joos S
Trials; 2015 Feb; 16():51. PubMed ID: 25887713
[TBL] [Abstract][Full Text] [Related]
17. The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context.
Kwakkenbos L; Jewett LR; Baron M; Bartlett SJ; Furst D; Gottesman K; Khanna D; Malcarne VL; Mayes MD; Mouthon L; Poiraudeau S; Sauve M; Nielson WR; Poole JL; Assassi S; Boutron I; Ells C; van den Ende CH; Hudson M; Impens A; Körner A; Leite C; Costa Maia A; Mendelson C; Pope J; Steele RJ; Suarez-Almazor ME; Ahmed S; Coronado-Montoya S; Delisle VC; Gholizadeh S; Jang Y; Levis B; Milette K; Mills SD; Razykov I; Fox RS; Thombs BD
BMJ Open; 2013 Aug; 3(8):. PubMed ID: 23929922
[TBL] [Abstract][Full Text] [Related]
18. [Cohort multiple randomized controlled trial: a solution for the evaluation of multiple interventions].
Verkooijen HM; Roes K; van Gils CH
Ned Tijdschr Geneeskd; 2013; 157(17):A5762. PubMed ID: 23614865
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic mastectomy for the prevention of breast cancer.
Lostumbo L; Carbine N; Wallace J; Ezzo J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
[TBL] [Abstract][Full Text] [Related]
20. Improving recruitment of older people to clinical trials: use of the cohort multiple randomised controlled trial design.
Clegg A; Relton C; Young J; Witham M
Age Ageing; 2015 Jul; 44(4):547-50. PubMed ID: 25857552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
